Trial site
University of Illinois Cancer Center
- 27running trials
- 11closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Head and neck cancer5 trials
- Acute myeloid leukaemia4 trials
- Gastric and oesophageal cancer4 trials
- Bladder cancer3 trials
- Endometrial cancer3 trials
- Liver and biliary tract cancer3 trials
- Multiple myeloma3 trials
- Myelodysplastic syndromes3 trials
- Acute lymphoblastic leukaemia2 trials
- Cervical cancer2 trials
- Follicular lymphoma2 trials
- and 13 more
- Phase
- Phase 216 trials
- Phase 37 trials
- Phase 1/26 trials
- Phase 15 trials
- Phase 2/31 trial
- Status
- Recruiting15 trials
- Active, not recruiting9 trials
- Completed8 trials
- Not yet recruiting3 trials
- Terminated3 trials
- Lead sponsor
- University of Illinois Chicago7 trials
- Alliance for Clinical Trials in Oncology2 trials
- Greg Durm, MD2 trials
- Inhibrx Biosciences, Inc2 trials
- Kari Wisinski2 trials
- and 23 more
Running trials
Recruiting
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
Not yet recruiting
GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Gastric and oesophageal cancer4 recruiting
- Head and neck cancer4 recruiting
- Bladder cancer3 recruiting
- Endometrial cancer3 recruiting
- Cervical cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Melanoma2 recruiting
- Multiple myeloma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Terminated
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Terminated
Completed
Terminated
Completed
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Recruiting
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Completed
Completed
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026